Nanotechnology and oncology: workshop summary
Gespeichert in:
| Format: | Elektronisch E-Book |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Washington, D.C.
National Academies Press
c2011
|
| Schlagworte: | |
| Online-Zugang: | FAW01 FAW02 Volltext |
| Beschreibung: | Includes bibliographical references (p. 69-71) Introduction -- - Uses of Nanotechnology in Oncology and Cancer Research -- - Research and Development of New Cancer Nanomedicines - Challenges and Solutions -- - Risks Associated with Nanotechnology -- - Standards and Regulation -- - Nanotechnology and the Public -- - Additional Challenges -- - Concluding Remarks "One way scientists are working to overcome challenges in cancer treatment and improve cancer care is through nanotechnology. Nanotechnology, engineered materials that make use of the unique physical properties, presents a new array of medical prospects that will revolutionize cancer prevention, diagnosis, and treatment practices. Giving new hope to patients, practitioners, and researchers alike, nanotechnology has the potential to translate recent discoveries in cancer biology into clinical advances in oncology. While public investments in nanotechnology for cancer continue to increase, medical products based on nanotechnology are already on the market. The National Cancer Policy forum held a workshop July 12-13, 2010, to explore challenges in the use of nanotechnology in oncology. Nanotechnology and Oncology evaluates the ongoing discussion on the role of nanotechnology in cancer as it relates to risk management, treatment, and regulatory policy. Assessments on nanomedicine and the physical properties of nanomaterials were presented during the workshop, along with an appraisal of the current status of research and development efforts."--Publisher's Website |
| Beschreibung: | 1 Online-Ressource (xii, 106 p.) |
| ISBN: | 0309163218 0309163226 1283151731 9780309163217 9780309163224 9781283151733 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV043076614 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 151126s2011 |||| o||u| ||||||eng d | ||
| 020 | |a 0309163218 |9 0-309-16321-8 | ||
| 020 | |a 0309163226 |c electronic bk. |9 0-309-16322-6 | ||
| 020 | |a 1283151731 |9 1-283-15173-1 | ||
| 020 | |a 9780309163217 |9 978-0-309-16321-7 | ||
| 020 | |a 9780309163224 |c electronic bk. |9 978-0-309-16322-4 | ||
| 020 | |a 9781283151733 |9 978-1-283-15173-3 | ||
| 035 | |a (OCoLC)746945424 | ||
| 035 | |a (DE-599)BVBBV043076614 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-1046 |a DE-1047 | ||
| 082 | 0 | |a 610.28 |2 23 | |
| 245 | 1 | 0 | |a Nanotechnology and oncology |b workshop summary |c Margie Patlak and Christine Micheel, rapporteurs ; National Cancer Policy Forum, Board on Health Care Services, Institute of Medicine of the National Academies |
| 264 | 1 | |a Washington, D.C. |b National Academies Press |c c2011 | |
| 300 | |a 1 Online-Ressource (xii, 106 p.) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 500 | |a Includes bibliographical references (p. 69-71) | ||
| 500 | |a Introduction -- - Uses of Nanotechnology in Oncology and Cancer Research -- - Research and Development of New Cancer Nanomedicines - Challenges and Solutions -- - Risks Associated with Nanotechnology -- - Standards and Regulation -- - Nanotechnology and the Public -- - Additional Challenges -- - Concluding Remarks | ||
| 500 | |a "One way scientists are working to overcome challenges in cancer treatment and improve cancer care is through nanotechnology. Nanotechnology, engineered materials that make use of the unique physical properties, presents a new array of medical prospects that will revolutionize cancer prevention, diagnosis, and treatment practices. Giving new hope to patients, practitioners, and researchers alike, nanotechnology has the potential to translate recent discoveries in cancer biology into clinical advances in oncology. While public investments in nanotechnology for cancer continue to increase, medical products based on nanotechnology are already on the market. The National Cancer Policy forum held a workshop July 12-13, 2010, to explore challenges in the use of nanotechnology in oncology. Nanotechnology and Oncology evaluates the ongoing discussion on the role of nanotechnology in cancer as it relates to risk management, treatment, and regulatory policy. Assessments on nanomedicine and the physical properties of nanomaterials were presented during the workshop, along with an appraisal of the current status of research and development efforts."--Publisher's Website | ||
| 650 | 4 | |a Neoplasms / therapy / Congresses | |
| 650 | 4 | |a Nanomedicine / Congresses | |
| 650 | 4 | |a Nanotechnology / Congresses | |
| 650 | 7 | |a MEDICAL / Allied Health Services / Medical Technology |2 bisacsh | |
| 650 | 7 | |a MEDICAL / Biotechnology |2 bisacsh | |
| 650 | 7 | |a MEDICAL / Family & General Practice |2 bisacsh | |
| 650 | 7 | |a MEDICAL / Lasers in Medicine |2 bisacsh | |
| 650 | 7 | |a TECHNOLOGY & ENGINEERING / Biomedical |2 bisacsh | |
| 650 | 4 | |a Medizin | |
| 650 | 4 | |a Nanomedicine |v Congresses | |
| 650 | 4 | |a Oncology |x Research |z United States |v Congresses | |
| 650 | 4 | |a Nanotechnology |v Congresses | |
| 650 | 4 | |a Cancer |x Treatment |v Congresses | |
| 651 | 4 | |a USA | |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |2 gnd-content | |
| 700 | 1 | |a Patlak, Margie |e Sonstige |4 oth | |
| 700 | 1 | |a Micheel, Christine |e Sonstige |4 oth | |
| 710 | 2 | |a Institute of Medicine (U.S.) |b Planning Committee on Policy Issues in Nanotechnology and Oncology |e Sonstige |4 oth | |
| 710 | 2 | |a National Cancer Policy Forum (U.S.) |e Sonstige |4 oth | |
| 856 | 4 | 0 | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=375279 |x Aggregator |3 Volltext |
| 912 | |a ZDB-4-EBA | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-028500806 | ||
| 966 | e | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=375279 |l FAW01 |p ZDB-4-EBA |q FAW_PDA_EBA |x Aggregator |3 Volltext | |
| 966 | e | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=375279 |l FAW02 |p ZDB-4-EBA |q FAW_PDA_EBA |x Aggregator |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804175464717090816 |
|---|---|
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV043076614 |
| collection | ZDB-4-EBA |
| ctrlnum | (OCoLC)746945424 (DE-599)BVBBV043076614 |
| dewey-full | 610.28 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 610 - Medicine and health |
| dewey-raw | 610.28 |
| dewey-search | 610.28 |
| dewey-sort | 3610.28 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>04245nmm a2200625zc 4500</leader><controlfield tag="001">BV043076614</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">151126s2011 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0309163218</subfield><subfield code="9">0-309-16321-8</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0309163226</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">0-309-16322-6</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1283151731</subfield><subfield code="9">1-283-15173-1</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780309163217</subfield><subfield code="9">978-0-309-16321-7</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780309163224</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">978-0-309-16322-4</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781283151733</subfield><subfield code="9">978-1-283-15173-3</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)746945424</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV043076614</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-1046</subfield><subfield code="a">DE-1047</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610.28</subfield><subfield code="2">23</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Nanotechnology and oncology</subfield><subfield code="b">workshop summary</subfield><subfield code="c">Margie Patlak and Christine Micheel, rapporteurs ; National Cancer Policy Forum, Board on Health Care Services, Institute of Medicine of the National Academies</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Washington, D.C.</subfield><subfield code="b">National Academies Press</subfield><subfield code="c">c2011</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (xii, 106 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references (p. 69-71)</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Introduction -- - Uses of Nanotechnology in Oncology and Cancer Research -- - Research and Development of New Cancer Nanomedicines - Challenges and Solutions -- - Risks Associated with Nanotechnology -- - Standards and Regulation -- - Nanotechnology and the Public -- - Additional Challenges -- - Concluding Remarks</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">"One way scientists are working to overcome challenges in cancer treatment and improve cancer care is through nanotechnology. Nanotechnology, engineered materials that make use of the unique physical properties, presents a new array of medical prospects that will revolutionize cancer prevention, diagnosis, and treatment practices. Giving new hope to patients, practitioners, and researchers alike, nanotechnology has the potential to translate recent discoveries in cancer biology into clinical advances in oncology. While public investments in nanotechnology for cancer continue to increase, medical products based on nanotechnology are already on the market. The National Cancer Policy forum held a workshop July 12-13, 2010, to explore challenges in the use of nanotechnology in oncology. Nanotechnology and Oncology evaluates the ongoing discussion on the role of nanotechnology in cancer as it relates to risk management, treatment, and regulatory policy. Assessments on nanomedicine and the physical properties of nanomaterials were presented during the workshop, along with an appraisal of the current status of research and development efforts."--Publisher's Website</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neoplasms / therapy / Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Nanomedicine / Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Nanotechnology / Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Allied Health Services / Medical Technology</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Biotechnology</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Family & General Practice</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Lasers in Medicine</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">TECHNOLOGY & ENGINEERING / Biomedical</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medizin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Nanomedicine</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Oncology</subfield><subfield code="x">Research</subfield><subfield code="z">United States</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Nanotechnology</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cancer</subfield><subfield code="x">Treatment</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="651" ind1=" " ind2="4"><subfield code="a">USA</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Patlak, Margie</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Micheel, Christine</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">Institute of Medicine (U.S.)</subfield><subfield code="b">Planning Committee on Policy Issues in Nanotechnology and Oncology</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">National Cancer Policy Forum (U.S.)</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=375279</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-028500806</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=375279</subfield><subfield code="l">FAW01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FAW_PDA_EBA</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=375279</subfield><subfield code="l">FAW02</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FAW_PDA_EBA</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift gnd-content |
| genre_facet | Konferenzschrift |
| geographic | USA |
| geographic_facet | USA |
| id | DE-604.BV043076614 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T07:16:42Z |
| institution | BVB |
| isbn | 0309163218 0309163226 1283151731 9780309163217 9780309163224 9781283151733 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-028500806 |
| oclc_num | 746945424 |
| open_access_boolean | |
| owner | DE-1046 DE-1047 |
| owner_facet | DE-1046 DE-1047 |
| physical | 1 Online-Ressource (xii, 106 p.) |
| psigel | ZDB-4-EBA ZDB-4-EBA FAW_PDA_EBA |
| publishDate | 2011 |
| publishDateSearch | 2011 |
| publishDateSort | 2011 |
| publisher | National Academies Press |
| record_format | marc |
| spelling | Nanotechnology and oncology workshop summary Margie Patlak and Christine Micheel, rapporteurs ; National Cancer Policy Forum, Board on Health Care Services, Institute of Medicine of the National Academies Washington, D.C. National Academies Press c2011 1 Online-Ressource (xii, 106 p.) txt rdacontent c rdamedia cr rdacarrier Includes bibliographical references (p. 69-71) Introduction -- - Uses of Nanotechnology in Oncology and Cancer Research -- - Research and Development of New Cancer Nanomedicines - Challenges and Solutions -- - Risks Associated with Nanotechnology -- - Standards and Regulation -- - Nanotechnology and the Public -- - Additional Challenges -- - Concluding Remarks "One way scientists are working to overcome challenges in cancer treatment and improve cancer care is through nanotechnology. Nanotechnology, engineered materials that make use of the unique physical properties, presents a new array of medical prospects that will revolutionize cancer prevention, diagnosis, and treatment practices. Giving new hope to patients, practitioners, and researchers alike, nanotechnology has the potential to translate recent discoveries in cancer biology into clinical advances in oncology. While public investments in nanotechnology for cancer continue to increase, medical products based on nanotechnology are already on the market. The National Cancer Policy forum held a workshop July 12-13, 2010, to explore challenges in the use of nanotechnology in oncology. Nanotechnology and Oncology evaluates the ongoing discussion on the role of nanotechnology in cancer as it relates to risk management, treatment, and regulatory policy. Assessments on nanomedicine and the physical properties of nanomaterials were presented during the workshop, along with an appraisal of the current status of research and development efforts."--Publisher's Website Neoplasms / therapy / Congresses Nanomedicine / Congresses Nanotechnology / Congresses MEDICAL / Allied Health Services / Medical Technology bisacsh MEDICAL / Biotechnology bisacsh MEDICAL / Family & General Practice bisacsh MEDICAL / Lasers in Medicine bisacsh TECHNOLOGY & ENGINEERING / Biomedical bisacsh Medizin Nanomedicine Congresses Oncology Research United States Congresses Nanotechnology Congresses Cancer Treatment Congresses USA (DE-588)1071861417 Konferenzschrift gnd-content Patlak, Margie Sonstige oth Micheel, Christine Sonstige oth Institute of Medicine (U.S.) Planning Committee on Policy Issues in Nanotechnology and Oncology Sonstige oth National Cancer Policy Forum (U.S.) Sonstige oth http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=375279 Aggregator Volltext |
| spellingShingle | Nanotechnology and oncology workshop summary Neoplasms / therapy / Congresses Nanomedicine / Congresses Nanotechnology / Congresses MEDICAL / Allied Health Services / Medical Technology bisacsh MEDICAL / Biotechnology bisacsh MEDICAL / Family & General Practice bisacsh MEDICAL / Lasers in Medicine bisacsh TECHNOLOGY & ENGINEERING / Biomedical bisacsh Medizin Nanomedicine Congresses Oncology Research United States Congresses Nanotechnology Congresses Cancer Treatment Congresses |
| subject_GND | (DE-588)1071861417 |
| title | Nanotechnology and oncology workshop summary |
| title_auth | Nanotechnology and oncology workshop summary |
| title_exact_search | Nanotechnology and oncology workshop summary |
| title_full | Nanotechnology and oncology workshop summary Margie Patlak and Christine Micheel, rapporteurs ; National Cancer Policy Forum, Board on Health Care Services, Institute of Medicine of the National Academies |
| title_fullStr | Nanotechnology and oncology workshop summary Margie Patlak and Christine Micheel, rapporteurs ; National Cancer Policy Forum, Board on Health Care Services, Institute of Medicine of the National Academies |
| title_full_unstemmed | Nanotechnology and oncology workshop summary Margie Patlak and Christine Micheel, rapporteurs ; National Cancer Policy Forum, Board on Health Care Services, Institute of Medicine of the National Academies |
| title_short | Nanotechnology and oncology |
| title_sort | nanotechnology and oncology workshop summary |
| title_sub | workshop summary |
| topic | Neoplasms / therapy / Congresses Nanomedicine / Congresses Nanotechnology / Congresses MEDICAL / Allied Health Services / Medical Technology bisacsh MEDICAL / Biotechnology bisacsh MEDICAL / Family & General Practice bisacsh MEDICAL / Lasers in Medicine bisacsh TECHNOLOGY & ENGINEERING / Biomedical bisacsh Medizin Nanomedicine Congresses Oncology Research United States Congresses Nanotechnology Congresses Cancer Treatment Congresses |
| topic_facet | Neoplasms / therapy / Congresses Nanomedicine / Congresses Nanotechnology / Congresses MEDICAL / Allied Health Services / Medical Technology MEDICAL / Biotechnology MEDICAL / Family & General Practice MEDICAL / Lasers in Medicine TECHNOLOGY & ENGINEERING / Biomedical Medizin Nanomedicine Congresses Oncology Research United States Congresses Nanotechnology Congresses Cancer Treatment Congresses USA Konferenzschrift |
| url | http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=375279 |
| work_keys_str_mv | AT patlakmargie nanotechnologyandoncologyworkshopsummary AT micheelchristine nanotechnologyandoncologyworkshopsummary AT instituteofmedicineusplanningcommitteeonpolicyissuesinnanotechnologyandoncology nanotechnologyandoncologyworkshopsummary AT nationalcancerpolicyforumus nanotechnologyandoncologyworkshopsummary |